Clinical and molecular investigation of Buschke-Fischer-Brauer in consanguineous Tunisian families.

C Charfeddine, C Ktaifi, N Laroussi, H Hammami, H Jmel, Z Landoulsi, T Badri, R Benmously, M Bchetnia, M S Boubaker, S Fenniche, S Abdelhak, M Mokni

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 2017;30(12):2122-2130

PMID: 27400994

Abstract

BACKGROUND

Punctate palmoplantar keratoderma type I (PPPK-BFB), also called Buschke-Fischer-Brauer disease (MIM 148600) is a rare autosomal dominant disorder of keratinization, characterized by multiple hyperkeratotic lesions on the palms and soles. Recently, PPPK-BFB has been shown to be associated with mutations in the AAGAB gene in several families of European, African, Canadian and Asian origins.

OBJECTIVE

To characterize the clinical and genetic features of PPPK-BFB in a broad group of Tunisian patients.

METHODS

Epidemiological and clinical data were collected from 18 PPPK-BFB patients belonging to eight Tunisian families. We carried out mutational and structural analysis for families not previously investigated.

RESULTS

Sequencing of the remaining families identified a total of three different mutations in AAGAB gene: one founder mutation (c.348_349delAG, p.R116Sfs*1) specific to the inbred Tunisian population, one recurrent mutation and (c.370C>T, p.R124*) one novel variant (c.430C>G, p.E144K). This novel mutation, involving a conserved amino acid, is predicted to be probably damaging to the p34 protein function. Assessment of the phenotypic presentation of this group of Tunisian patients was marked by variable severity and varying age at onset with a possible presence of anticipation noted in five out of eight families (62.5%). There is no apparent genotype-phenotype correlation. Despite the high degree of inbreeding, no homozygous individuals for AAGAB mutations were observed. Homozygous carriers in AAGAB gene are likely non-viable.

CONCLUSION

This study contributes to further characterize PPPK-BFB in consanguineous families and to extend the mutational spectrum of AAGAB gene in the Tunisian population.

© 2016 European Academy of Dermatology and Venereology.

Address: Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05), University of Tunis El Manar, Pasteur Institut of Tunis, Tunis, Tunisia.; High Institut of Biotechnology of Sidi Thabet, University of Manouba, Biotechpole of SidiThabet, Ariana, Tunisia.; Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05), University of Tunis El Manar, Pasteur Institut of Tunis, Tunis, Tunisia.; Department of Dermatology, Habib Thameur Hospital, Tunis, Tunisia.; Laboratory of Genodermatosis and Cancer (LR12SP03), University of Tunis El Manar, Faculty of Medecine Tunis, Tunis, Tunisia.; Department of Dermatology, Habib Thameur Hospital, Tunis, Tunisia.; Department of Human and Experimental Pathology, Pasteur Institute of Tunis, Tunis, Tunisia.; Department of Dermatology, CHU La Rabta Tunis, Tunis, Tunisia.; CHU La Rabta Tunis, Research Unit on Hereditary Keratinizaton Disorders UR12SP07, Tunis, Tunisia.

Link outs

Free resources

Other Literature Sources:

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.